Literature DB >> 18541893

Refractory thyroid cancer: a paradigm shift in treatment is not far off.

David G Pfister, James A Fagin.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18541893     DOI： 10.1200/JCO.2008.17.3682

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  19 in total

1.  Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer.

Authors:  James A Fagin; R Michael Tuttle; David G Pfister
Journal:  J Clin Endocrinol Metab       Date:  2010-06       Impact factor: 5.958

Review 2.  Molecular pathology of thyroid cancer: diagnostic and clinical implications.

Authors:  James A Fagin; Nicholas Mitsiades
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-12       Impact factor: 4.690

3.  Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8.

Authors:  Kevin T Bauerle; Rebecca E Schweppe; Gregory Lund; Gregory Kotnis; Gagan Deep; Rajesh Agarwal; Nikita Pozdeyev; William M Wood; Bryan R Haugen
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

4.  68Ga-PSMA: a One-stop Shop in Radioactive Iodine Refractory Thyroid Cancer?

Authors:  Thabo Lengana; Ismaheel O Lawal; Kgomotso Mokoala; Mariza Vorster; Mike M Sathekge
Journal:  Nucl Med Mol Imaging       Date:  2019-11-11

Review 5.  Partial remission of metastatic papillary thyroid carcinoma with sunitinib. Report of a case and review of the literature.

Authors:  Ph Kaldrymides; I Kostoglou-Athanassiou; A Gkountouvas; E Veniou; N Ziras
Journal:  Endocrine       Date:  2010-01-06       Impact factor: 3.633

6.  Inhibition of nuclear factor-kappa B differentially affects thyroid cancer cell growth, apoptosis, and invasion.

Authors:  Kevin T Bauerle; Rebecca E Schweppe; Bryan R Haugen
Journal:  Mol Cancer       Date:  2010-05-21       Impact factor: 27.401

7.  Autophagy: A potential target for thyroid cancer therapy (Review).

Authors:  Heqing Yi; Bin Long; Xuemei Ye; Lijun Zhang; Xiaodong Liu; Chunyan Zhang
Journal:  Mol Clin Oncol       Date:  2014-06-06

8.  Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.

Authors:  Eric Winer; Julie Gralow; Lisa Diller; Beth Karlan; Patrick Loehrer; Lori Pierce; George Demetri; Patricia Ganz; Barnett Kramer; Mark Kris; Maurie Markman; Robert Mayer; David Pfister; Derek Raghavan; Scott Ramsey; Gregory Reaman; Howard Sandler; Raymond Sawaya; Lynn Schuchter; John Sweetenham; Linda Vahdat; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2008-12-22       Impact factor: 44.544

Review 9.  Molecular markers of aggressiveness of thyroid cancer.

Authors:  Matthew D Ringel
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-10       Impact factor: 3.243

10.  FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes.

Authors:  Brittelle E Kessler; Vibha Sharma; Qiong Zhou; Xia Jing; Laura A Pike; Anna A Kerege; Sharon B Sams; Rebecca E Schweppe
Journal:  Mol Cancer Res       Date:  2016-06-03       Impact factor: 5.852
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.